Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 20389234)

1.

Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence in antiretroviral-experienced women.

Kelley CF, Sullivan ST, Lennox JL, Evans-Strickfaden T, Hart CE.

AIDS. 2010 Jun 1;24(9):1361-6. doi: 10.1097/QAD.0b013e3283394f3f.

PMID:
20389234
2.

Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy.

De Pasquale MP, Leigh Brown AJ, Uvin SC, Allega-Ingersoll J, Caliendo AM, Sutton L, Donahue S, D'Aquila RT.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):37-44.

PMID:
14501791
3.

Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations.

Tirado G, Jove G, Kumar R, Noel RJ, Reyes E, Sepulveda G, Yamamura Y, Kumar A.

Virology. 2004 Jul 1;324(2):577-86.

PMID:
15207642
4.

Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female.

Tirado G, Jove G, Kumar R, Noel RJ, Reyes E, Sepulveda G, Yamamura Y, Kumar A.

AIDS Res Hum Retroviruses. 2004 Jun;20(6):684-6.

PMID:
15242547
5.

Detection of multiple drug-resistance-associated pol mutations in cervicovaginal secretions from women largely treated with antiretroviral agents.

Di Stefano M, Fiore JR, Monno L, Lepera A, Pastore G, Angarano G.

AIDS. 1999 May 28;13(8):992-4. No abstract available.

PMID:
10371183
6.

HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaoundé, Cameroon.

Vessière A, Nerrienet E, Kfuţwah A, Menu E, Tejiokem M, Pinson-Recordon P, Barré-Sinoussi F, Fleury H, Ayouba A.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):256-8. No abstract available.

PMID:
16639353
7.

Differential evolution of cell-associated virus in blood and genital tract of HIV-infected females undergoing HAART.

Tirado G, Jove G, Reyes E, Sepulveda G, Yamamura Y, Singh DP, Kumar A.

Virology. 2005 Apr 10;334(2):299-305.

8.

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.

Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.

PMID:
20587857
9.

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study.

Verbiest W, Brown S, Cohen C, Conant M, Henry K, Hunt S, Sension M, Stein A, Stryker R, Thompson M, Schel P, Van Den Broeck R, Bloor S, Alcorn T, Van Houtte M, Larder B, Hertogs K.

AIDS. 2001 Mar 30;15(5):647-50. No abstract available.

PMID:
11317005
10.

Genotypic prediction of resistant mutation in HIV-1 pol gene towards the antiretroviral drugs.

Kumar A, Jadhav C.

Int J Bioinform Res Appl. 2011;7(1):15-23.

PMID:
21441094
11.

HIV-1 drug resistance in variants from the female genital tract and plasma.

Kemal KS, Burger H, Mayers D, Anastos K, Foley B, Kitchen C, Huggins P, Schroeder T, Picchio G, Back S, Gao W, Meyer WA 3rd, Weiser B.

J Infect Dis. 2007 Feb 15;195(4):535-45. Epub 2007 Jan 8.

12.

Genotypic drug resistance during HIV-1 primary infection in France (1996-1999): frequency and response to treatment.

Harzic M, Pellegrin I, Deveau C, Chaix ML, Dubeaux B, Garrigue I, Ngo N, Rouzioux C, Goujard C, Hoen B, Sereni D, Delfraissy JF, Meyer L; PRIMO Study Group.

AIDS. 2002 Mar 29;16(5):793-6. No abstract available.

PMID:
11964538
13.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

14.

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).

Machado DM, Fernandes SC, Succi RC, Freire WS, Pannuti CS, Gouveia AB, Levi JE, Diaz RS.

Rev Inst Med Trop Sao Paulo. 2005 Jan-Feb;47(1):1-5. Epub 2005 Feb 23.

15.

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.

Medeiros MS, Arruda EA, Guerrant RL, Brown C, Hammarskjold ML, Rekosh D, Lima AA.

Braz J Infect Dis. 2007 Aug;11(4):390-4. Erratum in: Braz J Infect Dis. 2007 Oct;11(5):528-9.

16.

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.

Cavalcanti AM, Lacerda HR, Brito AM, Pereira S, Medeiros D, Oliveira S.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):785-92. Epub 2007 Dec 11.

17.
18.

Prevalence of HIV-1 drug resistance in antiretroviral-naive pregnant Thai women.

Auswinporn S, Jenwitheesuk E, Panburana P, Sirinavin S, Vibhagool A, Chantratita W.

Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):818-21.

PMID:
12757232
19.

Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.

Arora SK, Gupta S, Toor JS, Singla A.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):125-30. doi: 10.1089/aid.2007.0156.

PMID:
18240959
20.

HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.

Cardoso LP, Queiroz BB, Stefani MM.

J Clin Virol. 2009 Oct;46(2):134-9. doi: 10.1016/j.jcv.2009.07.009. Epub 2009 Aug 13.

PMID:
19682948
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk